BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33161039)

  • 1. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
    Maritim S; Boulas P; Lin Y
    Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
    Soni PK; Saini TR
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations.
    Anderson M; Omri A
    Drug Deliv; 2004; 11(1):33-9. PubMed ID: 15168789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
    Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
    Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and characterization of liposome formulation by mixture design.
    Maherani B; Arab-tehrany E; Kheirolomoom A; Reshetov V; Stebe MJ; Linder M
    Analyst; 2012 Feb; 137(3):773-86. PubMed ID: 22158519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of hydrophilic gels containing coenzyme Q
    Dragicevic N; Krajisnik D; Milic J; Fahr A; Maibach H
    Drug Dev Ind Pharm; 2019 Jan; 45(1):43-54. PubMed ID: 30132719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flurbiprofen-loaded ethanolic liposome particles for biomedical applications.
    Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Verma K; Tak K; Reddy KR; Sadhu V
    J Microbiol Methods; 2019 Jun; 161():18-27. PubMed ID: 30951793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design.
    Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S
    Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
    Valizadeh H; Ghanbarzadeh S; Zakeri-Milani P
    Drug Dev Ind Pharm; 2015; 41(9):1558-65. PubMed ID: 25311425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of liposomes as drug delivery system for therapeutic applications.
    Guimarães D; Cavaco-Paulo A; Nogueira E
    Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.
    Venugopalarao G; Lakshmipathy R; Sarada NC
    Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):149-57. PubMed ID: 26491316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol.
    Huang M; Liang C; Tan C; Huang S; Ying R; Wang Y; Wang Z; Zhang Y
    Food Funct; 2019 Oct; 10(10):6447-6458. PubMed ID: 31524893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
    Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
    Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
    Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W
    Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
    Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
    Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, optimization, and
    Abdel-Rashid RS; Abd Allah FI; Hassan AA; Hashim FM
    J Liposome Res; 2021 Sep; 31(3):291-303. PubMed ID: 32762273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.